Journals / Tüberküloz ve Toraks / 2012 / Cilt: 60 - Sayı: 2

Bir Fas popülasyonunda uyku apne sendromu prevalansı çalışması

Study of the prevalence of sleep apnea syndrome's symptoms in a Moroccan population

Pages
108–113
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Polygraphy or poly-somnography is warranted to diagnose and have an exact prevalence in the Moroccan population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Sleep apnea syndrome is increasingly common in the general population and is under-diagnosed but we lackstudies on the estimation of its specific prevalence in several populations including Morocco.Materials and Methods: The aim of the study is to determine the prevalence of the main clinical symptoms of sleep apneasyndrome including snoring, witnessed apnea and excessive daytime sleepiness in a middle aged Moroccan populationthrough an epidemiological investigation in 288 men and 215 women, aged between 21 to 66 years who completed twoself-questionnaires: the Berlin questionnaire to assess sleep and the Epworth scale to assess daytime sleepiness.Results:The mean age was 42.7 years ± 14.3.
📊
Key Findings & Data:The Epworth Sleepiness Scale was on average 6.9 ± 3.4 (range: 1-16).
💡
Conclusion & Impact:Polygraphy or poly-somnography is warranted to diagnose and have an exact prevalence in the Moroccan population.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Sleep apnea syndrome is increasingly common in the general population and is under-diagnosed but we lackstudies on the estimation of its specific prevalence in several populations including Morocco.Materials and Methods: The aim of the study is to determine the prevalence of the main clinical symptoms of sleep apneasyndrome including snoring, witnessed apnea and excessive daytime sleepiness in a middle aged Moroccan populationthrough an epidemiological investigation in 288 men and 215 women, aged between 21 to 66 years who completed twoself-questionnaires: the Berlin questionnaire to assess sleep and the Epworth scale to assess daytime sleepiness.Results:The mean age was 42.7 years ± 14.3. The Epworth Sleepiness Scale was on average 6.9 ± 3.4 (range: 1-16). It wasabove 10 in 21.7% in favor of excessive daytime sleepiness. The prevalence of snoring and apnea was respectively 54.7%and 11.1% in the general population, 63.9% and 13.9% in men, 42.3% and 7.4% in women. Forty eight subjects (9.5%) inc-luding 13 women and 35 men had the combination of these three main clinical signs suggestive of sleep apnea syndrome.This subpopulation was older (p= 0.04) and with more overweight (p= 0.03) than the general population. Hypertension ra-te was not statistically higher in this subgroup.Conclusion: Prevalence of the main symptoms of sleep apnea syndrome is high in our study (9.5%). Polygraphy or poly-somnography is warranted to diagnose and have an exact prevalence in the Moroccan population.

Özet

Bir Fas popülasyonunda uyku apne sendromu prevalansı çalışmasıGiriş: Uyku apne sendromu genel popülasyonda gittikçe artan yaygın ve tanısız bir sendrom olup, Fası da içeren bazı po-pülasyonlarda spesifik prevalansıyla ilgili çalışma bulunmamaktadır.Materyal ve Metod: Bu çalışmanın amacı; 21-66 yaş aralığında, 288i erkek ve 215i kadından oluşan orta yaşlı bir Fas po-pülasyonunda epidemiyolojik araştırma ile horlama, tanıklı apne ve aşırı gündüz uykululuğu içeren uyku apne sendro-munun temel klinik semptomların prevalansını iki anket ile belirlemektir: uykuyu değerlendirmek için Berlin anketi vegündüz uykululuğunu değerlendirmek için Epworth skalası. Bulgular: Ortalama yaş 42.7 ± 14.3 yıldı. Epworth uykululuk skalası skoru ortalama 6.9 ± 3.4 (1-16) olarak bulundu veaşırı gündüz uykululuğu olanların %21.7sinde 10un üzerindeydi. Horlama ve apnenin genel popülasyonda prevalansı sı-rasıyla %54.7 ve %11.1, erkeklerde %63.9 ve %13.9, kadınlarda %42.3 ve %7.4tü. On üçü kadın, 35i erkek toplam 48 (%9.5)kişide uyku apne sendromunu düşündüren bu üç temel klinik bulgu mevcuttu. Bu subgrup genel popülasyona göre da-ha yaşlı (p= 0.04) ve daha kiloluydu (p= 0.03). Hipertansiyon varlığı bu subgrupta anlamlı olarak yüksek değildi.Sonuç: Çalışmamızda, uyku apne sendromunun temel semptomlarının prevalansı yüksekti (%9.5). Tanının konulması veFas popülasyonunda kesin prevalansın belirlenmesi için poligrafi veya polisomnografi gereklidir.

🔖

Cite This Article

JNIENE, A., ELFTOUH, M., ELFASSY, M. T. F. (2022). Bir Fas popülasyonunda uyku apne sendromu prevalansı çalışması. Tüberküloz ve Toraks, Cilt: 60 - Sayı: 2, 108–113. https://ajindex.com/articles/618709

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993
  2. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 2000
  3. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000
  4. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005
  5. McArdle N, Riha RL, Vennelle M, Coleman EL, Dennis MS, Warlow CP, et al. Sleep-disordered breathing as a risk factor for cerebrovascular disease: a case-control study in patients with transient ischemic attacks. Stroke 2003
  6. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Res- pir J 2006
  7. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sle- ep disordered breathing and coronary artery disease: long- term prognosis. Am J Respir Crit Care Med 2001
  8. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Ni- roumand M, Leung RS, Bradley TD. High prevalence of unre- cognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001
  9. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndro- me as a risk factor for hypertension: population study. BMJ 2000
  10. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Res- nick HE
  11. Sleep Heart Health Study Investigators. Sleep-disorde- red breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004
  12. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005
  13. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wil- ding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur He- art J 2004
  14. Prévalence des symptômes du syndrome d’apnées du somme- il. Étude dans une population française d’âge moyen. N. Mes- lier1, S. Vol2, B. Balkau3, F. Gagnadoux1, M. Cailleau2, A. Pet- rella2, J.L. Racineux1, J. Tichet2, et le gro